Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

NCT01381757 · clinicaltrials.gov ↗

TERMINATED

Status

34

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis, Pulmonary
Mycobacterium Tuberculous
Antitubercular Agents
Tuberculosis, Mulutidrug-Resistant
Extensively Drug-Resistant
Extensibely Drug-Resistant Tuberculosis

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)